BlackRock Inc. Decreases Stake in Agilent Technologies, Inc. $A

Key Points

• BlackRock reduced its Agilent Technologies stake by 1.2% in the second quarter, selling 303,661 shares. It still held 25.6 million shares, valued at approximately $3.4 billion, representing a 9.06% ownership stake.
• Agilent reported quarterly EPS of $1.49 and revenue of $1.83 billion, exceeding analyst estimates, while revenue grew 10% year over year. The company reaffirmed fiscal 2026 EPS guidance of $6.00–$6.10.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $160.24, compared with the stock’s reported price of $148.66.

BlackRock Inc. lowered its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 1.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,599,001 shares of the medical research company's stock after selling 303,661 shares during the period. BlackRock Inc. owned 9.06% of Agilent Technologies worth $3,400,315,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Fiduciary Trust Co boosted its stake in shares of Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company's stock worth $633,000 after buying an additional 77 shares during the last quarter. Sapient Capital LLC increased its stake in shares of Agilent Technologies by 4.2% during the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company's stock worth $240,000 after purchasing an additional 85 shares in the last quarter. Plan A Wealth LLC raised its holdings in shares of Agilent Technologies by 3.2% during the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company's stock valued at $403,000 after acquiring an additional 92 shares during the last quarter. IHT Wealth Management LLC lifted its holdings in Agilent Technologies by 4.9% in the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company's stock valued at $278,000 after purchasing an additional 96 shares in the last quarter. Finally, KPP Advisory Services LLC lifted its stake in shares of Agilent Technologies by 2.4% in the second quarter. KPP Advisory Services LLC now owns 4,382 shares of the medical research company's stock worth $582,000 after buying an additional 103 shares in the last quarter.

Agilent Technologies Stock Up 0.1%

A opened at $148.66 on Wednesday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The business has a 50 day moving average price of $135.97 and a two-hundred day moving average price of $125.68. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a market cap of $41.98 billion, a PE ratio of 29.85, a P/E/G ratio of 2.63 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts' consensus estimates of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. Agilent Technologies's quarterly revenue was up 10.0% on a year-over-year basis. During the same period last year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently commented on A. Weiss Ratings upgraded Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, June 2nd. HSBC dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Wednesday, June 3rd. TD Cowen upped their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Wall Street Zen raised Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Sunday, August 2nd. Finally, Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source